BBMC Endocrine Disorders2d agoBeyond glycemic control: differential effects of empagliflozin and sitagliptin on insulin sensitivity and a shared increase in adropin in type 2 diabetesOtbah Salim Taha·Heresh Moridi·Golnaz Azami·Lotfollah Saed·Mohammad Saeed HakhamaneshiRead at BMC Endocrine DisordersTagsPeroxisome Proliferator-Activated ReceptorsMolecular Biology
